학술논문

Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial
Document Type
Article
Source
In The Lancet Infectious Diseases October 2023 23(10):1143-1152
Subject
Primary Research
Articles
Language
ISSN
1473-3099